Article type:

We read with interest your article on the use of gabapen-tin pain control after burn debridement (1). Gabapentin has a well-established role in the management of neuro-pathic pain, and has been investigated in the past decade regarding its ability to potentiate the effect of morphine on postoperative pain, or decrease the amount of pain ex-perienced by patients after surgery. This study represents one of the only randomized, placebo-controlled, double-blind studies to look at gabapentin in burn patients. The authors found that 1200mg of gabapentin 2 hours prior to operative debridement of burn wounds led to a signifi-cant decrease in pain in the immediate 24-hour postoper-ative period, as measured by the visual analog score and by patient-requested morphine consumption. While the results are important and consistent with the growin